☆ 4.7 Article

Antimicrobial-Sensing Proteins in Obesity and Type 2 Diabetes The buffering efficiency hypothesis

DIABETES CARE (2011)

Get Full Text
Add to Collection

Journal

DIABETES CARE
Volume 34, Issue -, Pages S335-S341

Publisher

AMER DIABETES ASSOC
DOI: 10.2337/dc11-s238

Keywords

-

Categories

Endocrinology & Metabolism

Funding

  1. Ministerio de Educacion y Ciencia [SAF2008-02073]
  2. AstraZeneca
  3. Boehringer Ingelheim
  4. Bristol-Myers Squibb
  5. Daiichi Sankyo
  6. Eli Lilly
  7. Ethicon Endo-Surgery
  8. Generex Biotechnology
  9. F. Hoffmann-La Roche
  10. Janssen-Cilag
  11. Johnson Johnson
  12. Novo Nordisk
  13. Medtronic
  14. Pfizer

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.